Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

African pharmaceutical manufacture myth or reality presentation

832 views

Published on

A presentation delivered by Dr. Geoffrey Banda during a seminar organised by the Scinnovent Centre on 16 May 2014

  • Login to see the comments

African pharmaceutical manufacture myth or reality presentation

  1. 1.              
  2. 2.                
  3. 3. Source: GIZ (2011) EAC pharmaceutical manufacturing survey
  4. 4.           
  5. 5. Why the increased interest in African Pharma?  Estimated  IFC (2009)~US$3.8 billion by 2016, others forecast US$ 23 billion by 2020  Local manufacturers account for  Only 25–30%  Population  Current: 1.033 billion  Estimated: 1.3 billion by 2020
  6. 6.        
  7. 7.               http://www.strategyand.pwc.com/media/file/Strategyand_Pharma-Emerging-Markets-2.0.pdf
  8. 8.       
  9. 9. Increasingly there is purposive engagement to influence policy. However power and influence over policy and direction: Global Health Players/Institutions » Continental » Regional »Local institutions!!!
  10. 10. R&D; Reformulation Global Health Systems Local Health Sytem Financing
  11. 11.           Procurement as an Asset: Mackintosh and Chataway (2013) – Personal Communication
  12. 12.           
  13. 13. Reductions and Increase Country 2001 2011 Mozambique 14.8% 7.8% Chad 13.8% 3.3% DRC 2.8% 10.8% Achievers Country 2011 Rwanda 23.8% Liberia 18.9% Malawi 18.5% Zambia 16.0% Togo 15.4% Madagascar 15.3% Nearly There……. Country 2011 Swaziland 14.9% Ethiopia 14.6% Lesotho 14.6% Djibouti 14.2% https://www.devex.com/news/health-funding-in-africa-how-close-is-the-au-to-meeting-abuja-targets-81567 accessed 22/04/2014 MNCs see African pharmaceutical markets as a long term opportunity because of lack of assured public health financing If public health funding is resolved then local manufacturers will face intense competition from mature market players seeking new avenues for revenue and profit growth   
  14. 14. Source: Banda (2013). Finance as a forgotten technological capability for promoting African local pharmaceutical manufacture in Africa. International Journal of Technology Management and Sustainable Development. 12 (2)
  15. 15. Source: Banda (2013). Finance as a forgotten technological capability for promoting African local pharmaceutical manufacture in Africa. International Journal of Technology Management and Sustainable Development. 12 (2)
  16. 16.       

×